Health Highlights: Dec. 14, 2022
By Ernie Mundell HealthDay Reporter
New drug might be an advance against eczema. Rocatinlimab is a monoclonal antibody that researchers found prevented the recurrence of the symptoms of the skin condition for up to 20 weeks after treatment was stopped. Read more
Move to electric cars will save lives and billions in health care costs. Replacing vehicles powered by gas and diesel with electric ones will pay big dividends for Americans' health, a new study finds. Read more
Big U.S. genetics study is already helping participants. Called "All of Us," the study aims to eventually include at least 1 million people, in an effort to accelerate medical breakthroughs. Read more
Long COVID has taken the lives of more than 3,500 Americans. Research is revealing that the damage caused by a COVID infection poses a long-term risk to some who survive their bout with the coronavirus. Read more
The news stories provided in Health News and our Health-E News Newsletter are a service of the nationally syndicated HealthDay® news and information company. Stories refer to national trends and breaking health news, and are not necessarily indicative of or always supported by our facility and providers. This information is provided for informational and educational purposes only, and is not intended to be a substitute for medical advice, diagnosis, or treatment.